Astex Pharmaceuticals (ASTX) Q1 2012 Earnings Call April 30, 2012 4:30 pm ET Executives Timothy L. Enns - Senior Vice President of Investor Relations, Business Development & Corporate Communications James S. J. Manuso - Chairman of the Board and Chief Executive Officer Michael Molkentin - Chief Financial Officer, Principal Accounting Officer and Corporate Secretary Mohammad Azab - Chief Medical Officer Harren Jhoti - Founder, Chief Executive officer and Director Martin Buckland - Chief Business Officer and Director Analysts Robin Davison - Edison Investment Research Limited George B. Zavoico - McNicoll, Lewis & Vlak LLC, Research Division PresentationOperator
Good day, ladies and gentlemen, and thank you for standing by here at Astex Pharmaceuticals First Quarter 2012 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. And now, I'll turn the program over to Timothy Enns, Senior Vice President Corporate Communications and Marketing. Sir, the floor is yours. Timothy L. Enns Thank you, operator. Good day and thank you for joining us for Astex Pharmaceuticals 2012 First Quarter Financial Results Conference Call. With me today are Dr. James Manuso, Chairman and Chief Executive Officer; Dr. Harren Jhoti, President and member of the Board of Directors; Dr. Mohammad Azab, Chief Medical Officer; Dr. Martin Buckland, Chief Business Officer; and Michael Molkentin, Chief Financial Officer. In a few moments, Jim Manuso and Michael Molkentin will deliver remarks on the 2012 first quarter financial results and our business outlook for the year. After prepared comments, we will open the line for questions. Earlier today, we issued a press release with our financial results. A copy of the press release is available in the Investor Relations section of our website at www.astx.com. In addition, this call is being webcast and may be accessed via the Investor Relations section of our website. A webcast replay will be available for 30 days.